Skip to main content
. 2017 Jun 15;2(6):1066–1075. doi: 10.1016/j.ekir.2017.06.004

Table 1.

Baseline characteristics of participants by renal function

Characteristic Progressors Nonprogressors
Number of participants (%)
 All participants in category 390 1697
 Women 236 (60.5)a 732 (43.1)
 Diabetes mellitus 358 (91.8)a 1175 (69.2)
 Hypertension 110 (28.2)a 278 (16.4)
 UAE ≥20 μg/min 40 (10.3)b 89 (5.2)
 CDK273 signal ≥0.154 and <0.343 34 (8.7)c 99 (5.8)
 CKD273 signal ≥0.343 54 (13.8)a 76 (4.5)
Mean of characteristic
 Age (yr) 55.2 ± 11.7a 44.0 ± 15.0
 Systolic pressure (mm Hg) 131.4 ± 14.8a 124.7 ± 14.4
 Diastolic pressure (mm Hg) 77.3 ± 7.5 76.8 ± 8.3
 Mean arterial pressure (mm Hg) 95.4 ± 8.8a 92.7 ± 9.2
 Serum creatinine (μmol/L) 87.5 ± 12.4 88.4 ± 12.4
 eGFR (ml/min per 1.73 m2) 73.0 ± 9.93a 82.8 ± 12.9
 UAE (μg/min)c 6.76 (3.50 to 9.51)a 5.24 (3.12 to 7.08)
 CKD273 –0.17 ± 0.43a –0.40 ± 0.41
 Follow-up (yr) 4.73 (4.22–4.94)a 4.50 (4.16–5.11)
 eGFR data points 6 (5–6)a 5 (2–6)

Averages are arithmetic means ± SD or geometric means (interquartile range). Estimated glomerular filtration rate was derived from serum creatinine by the Chronic Kidney Disease Epidemiology Collaboration formula.

CKD273, urinary proteomic biomarker; eGFR, estimated glomerular filtration rate; UAE, urinary albumin excretion rate.

Progressors had an eGFR decrease by at least 10 ml/min per 1.73 m2 to less than 60 ml/min per 1.73 m2. P values indicate significance of the difference between progressors and nonprogressors.

a

P ≤ 0.0001.

b

P ≤ 0.001.

c

P ≤ 0.05.